Literature DB >> 23080062

Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles.

Mo Dan1, Daniel F Scott, Peter A Hardy, Robert J Wydra, J Zach Hilt, Robert A Yokel, Younsoo Bae.   

Abstract

PURPOSE: To develop cross-linked nanoassemblies (CNAs) as carriers for superparamagnetic iron oxide nanoparticles (IONPs).
METHODS: Ferric and ferrous ions were co-precipitated inside core-shell type nanoparticles prepared by cross-linking poly(ethylene glycol)-poly(aspartate) block copolymers to prepare CNAs entrapping Fe(3)O(4) IONPs (CNA-IONPs). Particle stability and biocompatibility of CNA-IONPs were characterized in comparison to citrate-coated Fe(3)O(4) IONPs (Citrate-IONPs).
RESULTS: CNA-IONPs, approximately 30 nm in diameter, showed no precipitation in water, PBS, or a cell culture medium after 3 or 30 h, at 22, 37, and 43°C, and 1, 2.5, and 5 mg/mL, whereas Citrate-IONPs agglomerated rapidly (> 400 nm) in all aqueous media tested. No cytotoxicity was observed in a mouse brain endothelial-derived cell line (bEnd.3) exposed to CNA-IONPs up to 10 mg/mL for 30 h. Citrate-IONPs (> 0.05 mg/mL) reduced cell viability after 3 h. CNA-IONPs retained the superparamagnetic properties of entrapped IONPs, enhancing T2-weighted magnetic resonance images (MRI) at 0.02 mg/mL, and generating heat at a mild hyperthermic level (40 ~ 42°C) with an alternating magnetic field (AMF).
CONCLUSION: Compared to citric acid coating, CNAs with a cross-linked anionic core improved particle stability and biocompatibility of IONPs, which would be beneficial for future MRI and AMF-induced remote hyperthermia applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23080062      PMCID: PMC4076800          DOI: 10.1007/s11095-012-0900-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  53 in total

Review 1.  Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects.

Authors:  Stefaan J H Soenen; Marcel De Cuyper
Journal:  Nanomedicine (Lond)       Date:  2010-10       Impact factor: 5.307

2.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

Review 3.  Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.

Authors:  Jason S Weinstein; Csanad G Varallyay; Edit Dosa; Seymur Gahramanov; Bronwyn Hamilton; William D Rooney; Leslie L Muldoon; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

Review 4.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

5.  Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging.

Authors:  Jinming Hu; Yinfeng Qian; Xiaofeng Wang; Tao Liu; Shiyong Liu
Journal:  Langmuir       Date:  2011-11-11       Impact factor: 3.882

6.  Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging.

Authors:  Michiaki Kumagai; Yutaka Imai; Teisaku Nakamura; Yuichi Yamasaki; Masaki Sekino; Shoogo Ueno; Kenjiro Hanaoka; Kazuya Kikuchi; Tetsuo Nagano; Eiji Kaneko; Kentaro Shimokado; Kazunori Kataoka
Journal:  Colloids Surf B Biointerfaces       Date:  2007-01-18       Impact factor: 5.268

7.  Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging.

Authors:  Jean-François Berret; Nicolas Schonbeck; Florence Gazeau; Delphine El Kharrat; Olivier Sandre; Annie Vacher; Marc Airiau
Journal:  J Am Chem Soc       Date:  2006-02-08       Impact factor: 15.419

8.  Synthesis of ultrasmall magnetic iron oxide nanoparticles and study of their colloid and surface chemistry.

Authors:  Galina Goloverda; Barry Jackson; Clayton Kidd; Vladimir Kolesnichenko
Journal:  J Magn Magn Mater       Date:  2009-05-01       Impact factor: 2.993

9.  Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension.

Authors:  Ratna Tantra; Jordan Tompkins; Paul Quincey
Journal:  Colloids Surf B Biointerfaces       Date:  2009-09-06       Impact factor: 5.268

10.  Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI.

Authors:  J Lodhia; G Mandarano; Nj Ferris; P Eu; Sf Cowell
Journal:  Biomed Imaging Interv J       Date:  2010-04-01
View more
  8 in total

1.  Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches.

Authors:  Derek Reichel; Louis T Curtis; Elizabeth Ehlman; B Mark Evers; Piotr Rychahou; Hermann B Frieboes; Younsoo Bae
Journal:  Pharm Res       Date:  2017-08-24       Impact factor: 4.200

2.  Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.

Authors:  Mo Dan; Younsoo Bae; Thomas A Pittman; Robert A Yokel
Journal:  Pharm Res       Date:  2014-11-07       Impact factor: 4.200

3.  Co-precipitation Synthesis of Near-infrared Iron Oxide Nanocrystals on Magnetically Targeted Imaging and Photothermal Cancer Therapy via Photoablative Protein Denature.

Authors:  Wei-Jhe Syu; Chih-Chia Huang; Jong-Kai Hsiao; Yao-Chang Lee; Yu-Tsang Huang; Parthiban Venkatesan; Ping-Shan Lai
Journal:  Nanotheranostics       Date:  2019-05-25

Review 4.  In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles.

Authors:  Ujwal S Patil; Shiva Adireddy; Ashvin Jaiswal; Sree Mandava; Benjamin R Lee; Douglas B Chrisey
Journal:  Int J Mol Sci       Date:  2015-10-15       Impact factor: 5.923

5.  Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.

Authors:  Mo Dan; David B Cochran; Robert A Yokel; Thomas D Dziubla
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

6.  Magnetic liposomes for colorectal cancer cells therapy by high-frequency magnetic field treatment.

Authors:  Andri Hardiansyah; Li-Ying Huang; Ming-Chien Yang; Ting-Yu Liu; Sung-Chen Tsai; Chih-Yung Yang; Chih-Yu Kuo; Tzu-Yi Chan; Hui-Ming Zou; Wei-Nan Lian; Chi-Hung Lin
Journal:  Nanoscale Res Lett       Date:  2014-09-15       Impact factor: 4.703

7.  A novel material of cross-linked styrylpyridinium salt intercalated montmorillonite for drug delivery.

Authors:  Jing Cui; Qingqing Wang; Xiaodong Chen; Qufu Wei
Journal:  Nanoscale Res Lett       Date:  2014-08-03       Impact factor: 4.703

8.  Comparison of ultrasmall IONPs and Fe salts biocompatibility and activity in multi-cellular in vitro models.

Authors:  Natalia Janik-Olchawa; Agnieszka Drozdz; Damian Ryszawy; Maciej Pudełek; Karolina Planeta; Zuzanna Setkowicz; Maciej Śniegocki; Andrzej Żądło; Beata Ostachowicz; Joanna Chwiej
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.